Organ Recovery Systems is beginning a commercial development program for the LifePort Liver Transporter1 which is currently anticipated for market availability in 2012. The LifePort Liver Transporter is designed to address important unmet needs in clinical liver preservation for transplantation. Studies will be ongoing throughout 2011. The company is also developing a new proprietary machine preservation solution for the liver.

In parallel, the company will be developing a variable temperature, multi-organ LifePort Workstation2, designed to smartly integrate with the LifePort family of machine perfusion transporters. The proprietary Workstation is an ‘Intensive Care Unit’ for organs, allowing ex-vivo organ care using a broad range of medical solutions at temperatures from 0°c-37°c, on-board medical gases, and state of the art organ viability monitoring. Organs will remain secure within a sealed sterile organ-specific cassette designed to work universally between the LifePort Transporters and Workstation.

David Kravitz, CEO, commented, “These are exciting and important steps for us as we build upon the initial success of our LifePort platform. Our approach to developing precision-engineered technology for transplantation requires consideration of the views and suggestions of the clinical community we serve. Over the next year, we will be working closely with procurement specialists and leading clinicians worldwide to help guide development of the LifePort Liver Transporter and our variable temperature, multi-organ Workstation. Our hope is that this suite of technologies will help to improve both the quality and availability of livers and other organs for transplantation and make a positive difference for patients on waiting lists around the world.”

In developing these new devices and solutions, the company is collaborating with Dr. James Guarrera and his clinical team at Columbia University Medical Center (New York) and the University Hospitals Leuven (Belgium), among others. Columbia University surgeons, led by Dr. Guarrera, recently reported in the American Journal of Transplantation the world's first series of successful clinical liver transplants employing hypothermic machine perfusion.

Organ Recovery Systems is teaming up again with leading international industrial design firm IDEO to drive product design and development. IDEO collaborated with Organ Recovery Systems in creating the award winning LifePort Kidney Transporter. The LifePort Kidney Transporter, LifePort Liver Transporter and LifePort Workstation are based on Organ Recovery Systems' patented and patent pending technology, as well as additional proprietary technology that is under development.

1.LifePort Liver Transporter is in the investigational stage of development and is not available for commercial sale.
2. LifePort Workstation is in the investigational stage of development and is not available for commercial sale.